Deregulated apoptosis is a hallmark of the Fanconi anemia syndrome.

Fanconi anemia (FA) is a genetic human disorder associated with bone marrow failure and predisposition to cancer. FA cells show poor growth capacity and spontaneous chromosomal anomalies as well as cellular and chromosomal hypersensitivity to DNA cross-linking agents such as mitomycin C (MMC). Because it is likely that disruption of the apoptotic control would lead to such a phenotype, we investigated the implication of apoptosis in the FA syndrome. It is shown that, although demonstrating a high frequency of spontaneous apoptosis, FA cells from four genetic complementation groups are deficient in gamma-ray-induced apoptosis and their MMC hypersensitivity is not due to apoptosis. Fas is a cell surface receptor belonging to the tumor necrosis factor receptor family and is involved in apoptosis. We show that, independently of DNA damage, the alteration in the control of apoptosis in FA concerns also the pathway initiated by Fas activation. Finally, ectopic expression of the wild-type FAC gene corrects the MMC hypersensitivity and anomalies in apoptosis and cell cycle response in FA cells. Altogether, these findings strongly implicate the FA genes as playing a major role in the control of apoptosis. Thus, further studies with FA syndrome will be instrumental toward molecularly dissecting the apoptotic pathways.

[1]  Z. Darżynkiewicz,et al.  Features of apoptotic cells measured by flow cytometry. , 1992, Cytometry.

[2]  E. Cundari,et al.  Analysis of susceptibility of mature human T lymphocytes to dexamethasone‐induced apoptosis , 1994, European journal of immunology.

[3]  R. Scott,et al.  Induction and removal of interstrand crosslinks in the ribosomal RNA genes of lymphoblastoid cell lines from patients with Fanconi anemia. , 1993, Mutation research.

[4]  P. Hanawalt,et al.  Repair analysis of mitomycin C-induced DNA crosslinking in ribosomal RNA genes in lymphoblastoid cells from Fanconi's anemia patients. , 1989, Mutation research.

[5]  H. Joenje,et al.  Oxygen-dependence of chromosomal aberrations in Fanconi's anaemia , 1981, Nature.

[6]  M. Buchwald,et al.  Evidence for at least four Fanconi anaemia genes including FACC on chromosome 9 , 1992, Nature Genetics.

[7]  J. Tilly,et al.  Microscale autoradiographic method for the qualitative and quantitative analysis of apoptotic DNA fragmentation , 1993, Journal of cellular physiology.

[8]  C. Mathew,et al.  Positional cloning of the Fanconi anaemia group A gene , 1996, Nature Genetics.

[9]  M. Raff,et al.  Social controls on cell survival and cell death , 1992, Nature.

[10]  I. Christensen,et al.  Discrimination of bromodeoxyuridine labelled and unlabelled mitotic cells in flow cytometric bromodeoxyuridine/DNA analysis. , 1994, Cytometry.

[11]  M. Buchwald,et al.  Susceptibility of Fanconi's anemia lymphoblasts to DNA-cross-linking and alkylating agents. , 1982, Cancer research.

[12]  M. Poot,et al.  BrdU-Hoechst Flow Cytometry Links the Cell Kinetic Defect of Fanconi Anemia to Oxygen Hypersensitivity , 1989 .

[13]  J. Lotem,et al.  Control of programmed cell death in normal and leukemic cells: new implications for therapy. , 1993, Blood.

[14]  J. Remacle,et al.  Low levels of reactive oxygen species as modulators of cell function. , 1995, Mutation research.

[15]  M. Bender,et al.  G2 chromosomal radiosensitivity in Fanconi's anemia. , 1979, Mutation research.

[16]  V. Fadok,et al.  Apoptosis and programmed cell death in immunity. , 1992, Annual review of immunology.

[17]  W. R. Shannon,et al.  Cloning of cDNAs for Fanconi's anaemia by functional complementation , 1992, Nature.

[18]  E. Gluckman,et al.  Radiosensitivity in Fanconi anaemia: application to the conditioning regimen for bone marrow transplantation , 1983, British journal of haematology.

[19]  M. Buchwald,et al.  Suppression of apoptosis in hematopoietic factor-dependent progenitor cell lines by expression of the FAC gene. , 1996, Blood.

[20]  Erythroid failure in Diamond-Blackfan anemia is characterized by apoptosis. , 1994 .

[21]  R. G. Allen,et al.  Leukemia and preleukemia in Fanconi anemia patients. A review of the literature and report of the International Fanconi Anemia Registry. , 1991, Cancer genetics and cytogenetics.

[22]  H. Youssoufian.  Cytoplasmic localization of FAC is essential for the correction of a prerepair defect in Fanconi anemia group C cells. , 1996, The Journal of clinical investigation.

[23]  S. Nagata,et al.  The Fas death factor , 1995, Science.

[24]  P. Hanawalt,et al.  DNA repair in human cells containing photoadducts of 8-methoxypsoralen or angelicin. , 1980, Cancer research.

[25]  M. Buchwald,et al.  Fanconi anemia and novel strategies for therapy. , 1994, Blood.

[26]  A. Taylor,et al.  Effects of ionizing radiation on cells from Fanconi's anemia patients. , 1985, Cancer research.

[27]  D. Averbeck,et al.  The fate of 8-methoxypsoralen-photoinduced DNA interstrand crosslinks in Fanconi's anemia cells of defined genetic complementation groups. , 1987, Mutation research.

[28]  T. K. van den Berg,et al.  Fanconi anemia genes act to suppress a cross-linker-inducible p53-independent apoptosis pathway in lymphoblastoid cell lines. , 1996, Blood.

[29]  R. Weichselbaum,et al.  DNA repair in a Fanconi's anemia fibroblast cell strain. , 1979, Biochimica et biophysica acta.

[30]  S. Nagata,et al.  Purification and characterization of the Fas-ligand that induces apoptosis , 1994, The Journal of experimental medicine.

[31]  S. Yonehara,et al.  A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor , 1989, The Journal of experimental medicine.

[32]  T. Soussi,et al.  p53-dependent pathway of radio-induced apoptosis is altered in Fanconi anemia. , 1995, Oncogene.

[33]  M. W. Thompson,et al.  Specific cellular defects in patients with Fanconi anemia , 1979, Journal of cellular physiology.